Convergence of CRISPR and Stem Cells is Changing Regenerative Medicine | Cure8bio CEO, Faizzan Ahmad

Unlocking Female Longevity: Redefining Menopause as a Choice | Celmatix CEO, Dr. Piraye Yurttas Beim

Dr. Piraye Yurttas Beim, a molecular biologist and entrepreneur, is revolutionizing women's health through her groundbreaking work at Celmatix. With an impressive educational background from the University of Texas at Austin, Cornell University, and the University of Cambridge, Dr. Beim is using her expertise to accelerate precision medicine in women's health. Learn about her journey and the impact she's making in this fascinating interview.

Building a $500M Investment Firm: Lessons from a Beverage Mogul | Ground Force Capital Managing Partner, Mark Rampolla

Mark Rampolla, Managing Partner at Ground Force Capital, shares his journey from Peace Corps volunteer to creating a billion-dollar brand. Discover how he navigated the beverage industry, sold to Coca-Cola, and then bought back his company to rebuild it even bigger. Rampolla also discusses his transition into venture capital and the exciting companies in his portfolio.

Unlocking the Immune System to Combat Aging | Deciduous Therapeutics CEO, Robin Mansukhani

Deciduous CEO Robin Mansukhani discusses how their company is working on harnessing the immune system to treat diseases of aging. Robin explains the concept of senescent cells and how their accumulation can lead to various age-related diseases such as pulmonary fibrosis, type 2 diabetes, and even dementias. He also shares insights on the potential of longevity therapeutics to revolutionize medicine by targeting multiple indications simultaneously.

Convergence of CRISPR and Stem Cells is Changing Regenerative Medicine | Cure8bio CEO, Faizzan Ahmad

Join Dr. Faizzan Ahmad, CEO of Cure8bio, as he explores the frontier of regenerative medicine. From his journey at Oxford to pioneering a hub-and-spoke biotech model, Dr. Ahmad discusses the latest advancements in stem cell therapies, gene editing, and their potential to cure previously untreatable diseases. Learn how these innovations are reshaping the future of healthcare and longevity.

Regenerative Medicine is the Future of Healthcare | Pluri CEO, Yaky Yanay

Discover how Yaky Yanay, CEO of Pluri, is revolutionizing regenerative medicine using placenta-derived cells. From combating radiation exposure to potentially extending human lifespan, Yanay shares insights on the future of healthcare and the untapped potential of cellular therapies.